US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist
  • 2.7100
  • -0.0400-1.45%
Close Jul 22 16:00 ET
  • 2.7000
  • -0.0100-0.37%
Post 17:32 ET
5.84MMarket Cap-383P/E (TTM)

GT Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.66%3.09M
-36.13%13.58M
-45.17%3.17M
-55.55%3.12M
20.14%3.62M
-32.65%3.67M
-63.04%21.26M
-68.21%5.78M
17.95%7.02M
-31.20%3.01M
Selling and administrative expenses
14.84%2.31M
-42.87%7.11M
-38.32%1.81M
-58.93%1.76M
-18.61%1.53M
-39.94%2.02M
-74.03%12.45M
-75.27%2.94M
-13.47%4.28M
-49.89%1.88M
-General and administrative expense
----
----
----
----
-18.61%1.53M
----
----
----
----
-49.89%1.88M
Research and development costs
-52.91%777K
-26.61%6.47M
-52.25%1.36M
-50.27%1.36M
83.93%2.1M
-20.94%1.65M
-8.13%8.81M
-54.92%2.84M
172.12%2.74M
78.25%1.14M
Operating profit
15.66%-3.09M
36.13%-13.58M
45.17%-3.17M
55.55%-3.12M
-20.14%-3.62M
32.65%-3.67M
63.04%-21.26M
68.21%-5.78M
-17.95%-7.02M
31.20%-3.01M
Net non-operating interest income expense
395.83%142K
99.65%567K
35.34%180K
101.87%216K
508.33%219K
-700.00%-48K
141.76%284K
931.25%133K
234.38%107K
36K
Non-operating interest income
-13.41%142K
167.12%780K
27.66%180K
101.87%216K
511.11%220K
1,950.00%164K
668.42%292K
2,250.00%141K
234.38%107K
--36K
Non-operating interest expense
--0
2,562.50%213K
--0
--0
--1K
--212K
-98.89%8K
-63.64%8K
--0
--0
Other net income (expense)
-80.41%683K
5,980.90%5.41M
-57.38%26K
1,300.00%490K
141,100.00%1.41M
58,200.00%3.49M
-51.10%89K
-64.53%61K
-92.54%35K
99.79%-1K
Gain on sale of security
-77.79%656K
5,343.82%4.85M
-90.16%6K
1,300.00%490K
139,700.00%1.4M
49,316.67%2.95M
-51.10%89K
-64.53%61K
-92.54%35K
99.79%-1K
Special income (charges)
--0
--547K
--0
--0
--14K
--533K
--0
--0
--0
--0
-Less:Other special charges
----
---547K
--0
----
---14K
---533K
----
----
----
----
Other non- operating income (expenses)
--27K
--20K
----
----
----
----
----
----
----
----
Income before tax
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
Income tax
Net income
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
Net income continuous Operations
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
Minority interest income
Net income attributable to the parent company
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-898.24%-2.27M
63.62%-7.6M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227K
64.00%-20.88M
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
Basic earnings per share
-680.95%-1.64
71.31%-5.5836
60.82%-1.9836
72.73%-1.8
50.00%-1.5
95.88%-0.21
68.51%-19.4634
67.54%-5.0634
-29.41%-6.6
33.33%-3
Diluted earnings per share
-680.95%-1.64
71.31%-5.5836
60.82%-1.9836
72.73%-1.8
50.00%-1.5
95.88%-0.21
68.51%-19.4634
67.54%-5.0634
-29.41%-6.6
33.33%-3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.66%3.09M-36.13%13.58M-45.17%3.17M-55.55%3.12M20.14%3.62M-32.65%3.67M-63.04%21.26M-68.21%5.78M17.95%7.02M-31.20%3.01M
Selling and administrative expenses 14.84%2.31M-42.87%7.11M-38.32%1.81M-58.93%1.76M-18.61%1.53M-39.94%2.02M-74.03%12.45M-75.27%2.94M-13.47%4.28M-49.89%1.88M
-General and administrative expense -----------------18.61%1.53M-----------------49.89%1.88M
Research and development costs -52.91%777K-26.61%6.47M-52.25%1.36M-50.27%1.36M83.93%2.1M-20.94%1.65M-8.13%8.81M-54.92%2.84M172.12%2.74M78.25%1.14M
Operating profit 15.66%-3.09M36.13%-13.58M45.17%-3.17M55.55%-3.12M-20.14%-3.62M32.65%-3.67M63.04%-21.26M68.21%-5.78M-17.95%-7.02M31.20%-3.01M
Net non-operating interest income expense 395.83%142K99.65%567K35.34%180K101.87%216K508.33%219K-700.00%-48K141.76%284K931.25%133K234.38%107K36K
Non-operating interest income -13.41%142K167.12%780K27.66%180K101.87%216K511.11%220K1,950.00%164K668.42%292K2,250.00%141K234.38%107K--36K
Non-operating interest expense --02,562.50%213K--0--0--1K--212K-98.89%8K-63.64%8K--0--0
Other net income (expense) -80.41%683K5,980.90%5.41M-57.38%26K1,300.00%490K141,100.00%1.41M58,200.00%3.49M-51.10%89K-64.53%61K-92.54%35K99.79%-1K
Gain on sale of security -77.79%656K5,343.82%4.85M-90.16%6K1,300.00%490K139,700.00%1.4M49,316.67%2.95M-51.10%89K-64.53%61K-92.54%35K99.79%-1K
Special income (charges) --0--547K--0--0--14K--533K--0--0--0--0
-Less:Other special charges -------547K--0-------14K---533K----------------
Other non- operating income (expenses) --27K--20K--------------------------------
Income before tax -898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M-26.19%-6.88M38.72%-2.98M
Income tax
Net income -898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M-26.19%-6.88M38.72%-2.98M
Net income continuous Operations -898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M-26.19%-6.88M38.72%-2.98M
Minority interest income
Net income attributable to the parent company -898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M-26.19%-6.88M38.72%-2.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -898.24%-2.27M63.62%-7.6M46.96%-2.96M64.89%-2.42M33.13%-1.99M95.83%-227K64.00%-20.88M69.02%-5.58M-26.19%-6.88M38.72%-2.98M
Basic earnings per share -680.95%-1.6471.31%-5.583660.82%-1.983672.73%-1.850.00%-1.595.88%-0.2168.51%-19.463467.54%-5.0634-29.41%-6.633.33%-3
Diluted earnings per share -680.95%-1.6471.31%-5.583660.82%-1.983672.73%-1.850.00%-1.595.88%-0.2168.51%-19.463467.54%-5.0634-29.41%-6.633.33%-3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg